Edge
StocktwitsEarnings

Official STOCKTWITS Representative
$COLL Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.46 down -221.05% YoY
• Reported revenue of $199.88M up 6.32% YoY
• Collegium Pharmaceutical updated its full-year 2026 guidance, now expecting product revenues between $825 million and $855 million and adjusted EBITDA between $445 million and $470 million for the full year.